Journals / Bakırköy Tıp Dergisi / 2018 / Cilt: 14 - Sayı: 1

Management of Cardiac Myxoma; Tertiary Academic Center Experience

Kardiyak miksoma tedavisi; üçüncü basamak akademik merkez deneyimi

Pages
98–103
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The mainstays of current treatment strategy are surgical intervention with complete resection of tumor mass without any complications, and prevention of recurrence.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study, our clinical experience on cardiac myxoma, being the most frequently seen primary cardiac tumor is presented.
📊
Key Findings & Data:Material and Methods: In the present study, demographic data, presenting symptoms, clinical findings and when deemed necessary, coronary angiography results of 45 primary cardiac myxoma patients who were diagnosed, and operated between November 2010 and July 2016, were evaluated.
💡
Conclusion & Impact:The mainstays of current treatment strategy are surgical intervention with complete resection of tumor mass without any complications, and prevention of recurrence.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: In this study, our clinical experience on cardiac myxoma, being the most frequently seen primary cardiac tumor is presented. Material and Methods: In the present study, demographic data, presenting symptoms, clinical findings and when deemed necessary, coronary angiography results of 45 primary cardiac myxoma patients who were diagnosed, and operated between November 2010 and July 2016, were evaluated. Results: Of 45 included cases, 34 (75.6%) had left atrial, the remaining 11 (24.4%) had right atrial myxoma. Postoperative echocardiography was performed with no residual myxoma or recurrence. Conclusion: Since presenting symptoms are often nonspecific, high degree of clinical suspicion is necessary to diagnose cardiac tumors. The mainstays of current treatment strategy are surgical intervention with complete resection of tumor mass without any complications, and prevention of recurrence.

Özet

Amaç: Bu çalışmada, en sık görülen primer kalp tümörü olan miksomaların klinik özellikleri ve cerrahi deneyimlerimiz paylaşıldı. Gereç ve Yöntem: Kasım 2010-Temmuz 2016 tarihleri arasında 45 primer kardiyak miksoma hastasına tanı konularak opere edildi. Bu hastaların demografik özellikleri, semptomları, klinik bulguları, ekokardiyografi ve gerekli olanlara uygulanan koroner anjıografi bulguları değerlendirildi. Bulgular: Toplam 45 hastanın 34 tanesinde (%75.6) sol atriyum 11 tanesinde (%24.4) sağ atriyum kaynaklı miksoma tespit edildi. Postoperatif dönemde hastaların ekokardiyografi kontrollerinde rezidü ve rekürrense rastlanmadı. Sonuç: Klinik bulguları nonspesifik oldugu için başlangıçta kardiyak tümörlerin akla getirilmesi çok önemlidir. Tek tedavi seçeneği cerrahi olup, komplikasyon gelişmeden cerrahinin planlanması ve tümörün tam rezeke edilerek rekürrensin önlenmesi çok önemlidir

🔖

Cite This Article

KAVALA, A. A., TURKYİLMAZ, S. (2022). Management of Cardiac Myxoma; Tertiary Academic Center Experience. Bakırköy Tıp Dergisi, Cilt: 14 - Sayı: 1, 98–103. https://ajindex.com/articles/460085

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Shinfeld A, Katsumata T, Westaby S. Recurrent cardiac myxoma: seeding or multifocal disease? Ann Thorac Surg 1998;66:285-8.[CrossRef] Aydoğan H, Akay MH, Orhan G ve ark. Miksomaların cerrahi tedavisi. HKK Cerrah Bül 1999;7:34-7.
  2. Eralp A, Kutsal A, İbrişim E, Şener E, Babacak K, Bayazıt K. Atrial miksoma ve cerrahi tedavisi. Ankara Tıp Mecmuası 1989;42:535-44.
  3. Symbas PN, Hatcher CR, Gravanis MB. Myxoma of the heart: Clinical and experimental observations. Ann Surg 1976;183:470-4.[CrossRef] Bortolotti U, Maraglino G, Rubino M, et al. Surgical excision of intracardiac myxomas: A 20 year follow-up. Ann Thorac Surg 1990;49:449-53. [CrossRef] Kirklin JW, Barratt-Boyes. Cardiac tumor. In: Kirklin JW, Barratt-Boyes BG. Cardiac Surgery, 2nd edition, New York, Churchill Livingstone, Vol 2, 1993; 1635-1654.
  4. Bozoğlan O, Erdem K, Güneş T, Gül A, Yılmaz Y, Erdogan H. Kardiyak miksomalar ve cerrahi tedavi. Abant İzzet Baysal Tıp Fakültesi Dergisi 2012;7(1-2-3).
  5. Oto Ö, Okutan H, Kutluk K ve ark. Strok ve miksoma. Türk Göğüs Kalp Damar Cer Derg 1998;6:493-7.
  6. Süzer K, Aytaç A, Akçevin A ve ark. Cerrahi açıdan kalp tümörleri: 20 vakaya ait deneyim ve gözden geçiri. Türk Kardiyol Dern Arş 1990;18:56-62.
  7. Keçeligil T, Demir Z, Kolbakır F, Demirbağ K, Akar H.Kardiyak miksoma ve cerrahi tedavisi. GKDC Dergisi 1999;7:210-6.
  8. Yılman M, Kolbakır F, Keçeligil HT, Geyik T, Erk MK. Mitral anulustan orijin alan miksoma. Türk Göğüs Kalp Damar Cer Derg 1994;2:159-61.
  9. Selvaraj A, Kumar R, Ravikumar E. Surgical management of right atriyal myxomas. A 15 year experience with review of the literature. J Cardiovasc Surg (Torino) 1999;40:101-5.
  10. Talwalkar N, Livesay JJ, Treistman B, Lacle CE. Mobilization of the anterior mitral leaflet for excision of a left ventricular myxoma. Ann Thorac Surg 1999;67:1476-8. [CrossRef Wold LE, Lie JT. Cardiac myxomas: A clinicopathologic profile. Am J Pathol 1980;101:219-22. Prichard RW. Tumors of the heart: Review of the subject and report of one hundred and fifty cases. Arch pathol 1951;51:98-104.
  11. Gelder HM, Oi Brian DJ, Styles ED, Alexander JA. Familial cardiac myxoma. Ann Thorac Surg 1992;53:419-24. [CrossRef] Lee VH, Connolly HM, Brown RD Jr. Central nervous system manifestations of cardiac myxoma. Arch Neurol Aug 2007;64(8):1115-20. Roldán FJ, Vargas-Barrón J, Espinola-Zavaleta N, Keirns C, Romero-Cárdenas A. Recurrent myxoma implanted in the left atriyal appendage. Echocardiography 2000;17:169-71. [CrossRef] Lucacs L, Lengyel M, Szedö F, et al. Surgical tr